Amarin Corp Plc (AMRN)

[Whalatane]

ALT

My reading of why Dr Jenkins is convening the council is that he wants to buttress himself and the FDA for what ever comes after they make their decision.

This decision IMHO will have huge health and financial consequences

If they approve Anchor they are saying that there is enough evidence to argue that 4gms of Vascepa reduces risk of a heart attack for those with TG's between 200-500 on Statin therapy. ( at least that is how IMHO it will be read )

If they make that kind of announcement then it should change the prescribing habits of thousands of MD's across the US .

Kaiser in CA for example refuses to prescribe Vascepa for this TG range because they claim " literature does not show benefit " in a US population. With FDA approval this should change

Theres also insurance coverage . If you get an MD to write a script for TG's 200-500 , insurance often will not cover because its is not an "on label " script ...that should also change ( if Anchor is approved )

For the record ...I'm just looking for an expanded label ...BUT if they come out and flat out approve use for anyone with TGs 200-500 on Statins OR ...deny it completely ...it will be huge news
JMO
Kiwi